H-1B sponsorship profile: Unicon Pharma Inc. Across U.S. Department of Labor LCA disclosures, Unicon Pharma Inc filed 258 Labor Condition Applications covering 258 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 69% (178 certified of 258 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Unicon Pharma Inc’s H-1B petitions range from $60,000 at the low end to $200,000 at the high end, with a petition-weighted average of $87,065. That range reflects the mix of occupations the company sponsors, led by Validation Engineer (97 petitions at $88,630 avg), followed by Validation Analyst and CQV Engineer. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Unicon Pharma Inc is headquartered in South Plainfield, NJ under NAICS code 5613, and places H-1B workers across 18 states, most heavily in NJ, NC, NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.